K-M curves derived from CPTAC clinical proteomic datasets demonstrated significantly worse overall survival in patients with elevated ACC1 protein levels, particularly in those with kidney cancer, liver cancer, uterine cancer, and lung adenocarcinoma (Supplementary Figures 2C–F). This evidence concerns the gene ACACA and lung adenocarcinoma.